EMA Authorised: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine;tenofovir disoproxil maleate) — Mylan Pharmaceuticals Limited

View source ↗

Summary

Emtricitabine/tenofovir disoproxil Mylan has been authorised for use in HIV infections in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil (emtricitabine;tenofovir disoproxil maleate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Mylan Pharmaceuticals Limited. Decision date: 08/06/2026